Parasitic Infestions


Where and how does one acquire cutaneous parasitic diseases?

Parasitic skin diseases may arise from systemic spread or direct penetration of the skin. Cutaneous parasitic infestations are a major source of morbidity, affecting millions worldwide. Tropical climates, crowding, poor nutrition, sanitation problems, and limited medical resources are all associated with increased variety and severity of parasitoses. Ecologically temperate climates and industrialized societies are also afflicted by significant parasitic infestations because of local vectors, distant vacations, and widespread travel to and from areas of endemic infection for business, political, humanitarian, or military purposes. Immunosuppression due to drugs or disease leads to cutaneous manifestations of parasitic diseases that may be caused by unusual organisms.

What is “creeping eruption?”

Properly known as cutaneous larva migrans, and popularly known as “sandworms,” creeping eruption occurs when the larva of dog and cat hookworms ( Ancylostoma caninum and A. braziliense , respectively) penetrate intact, exposed skin and begin migrating through the epidermis. The most common location for the eruption is the sole of the foot, although other sites such as the buttocks, back, and thighs, which may have rested on contaminated sand, are susceptible. Lacking the enzymes necessary to penetrate and survive in the deeper dermis, the larvae wander a serpiginous route at a speed up to 3 cm/day. Clinically, the primary lesion is a pruritic, erythematous, serpiginous burrow ( Fig. 32.1 ). Although the larvae usually die in 2 to 8 weeks, survival up to 22 months has been reported. Several cases of cutaneous larva migrans–related erythema multiforme have been reported.

Fig. 32.1, Creeping eruption. Cutaneous larva migrans due to canine hookworm.

A variety of other animal hookworm species may also cause creeping eruption. Human hookworms may briefly cause a similar eruption, but the better-adapted parasites soon find their way into the circulation.

Richey TK, Gentry RH, Fitzpatrick JE, Morgan AM. Persistent cutaneous larva migrans due to Ancylostoma species . South Med J. 1996;89:609–611.

Vaughan TK, English JC III. Cutaneous larva migrans complicated by erythema multiforme. Cutis. 1998;62:33–35.

How do you treat creeping eruption?

An older method was to freeze the leading point of the burrow. This sometimes produced significant tissue destruction and often missed the larva, which may be up to 2 cm ahead of the visible burrow. Oral ivermectin and albendazole are treatment option. One or two sequential doses of oral ivermectin (200 mcg/kg) is the preferred treatment for uncomplicated cases given its wide availability, safety, and high cure rate (94%–100%). A classic treatment is 10% topical thiabendazole suspension applied four times a day for at least 2 days after the last sign of burrow activity. This regimen has a high cure rate and minimal toxicity, but this medication is not always readily available.

Schuster A, Lesshafft H, Reichert F, et al. Hookworm-related cutaneous larva migrans in northern Brazil: resolution of clinical pathology after a single dose of ivermectin. Clin Infect Dis. 2013;57(8):1155–1157.

What is different about larva currens?

Larva currens, or “racing larva,” is caused by Strongyloides stercoralis , a nematode with a normal life cycle similar to the hookworm. Strongyloides , however, is unique in that it can complete its life cycle within the human host and bypass the obligate soil phase of the hookworms. Autoinfection may occur to a point of overwhelming infestation and host death, especially in immunocompromised patients. The serpentine eruption of larva currens appears much the same as creeping eruption but is more likely to occur on the thighs, buttocks, or perineum due to larval penetration from the nearby colon. The eruption is more fleeting and lasts no more than a few days, during which the larva's migratory speed through the dermis may be clocked at up to 10 cm/hour ( Fig. 32.2 ). A nonspecific rash or hives may also occur because of hypersensitivity to the parasite. Ivermectin is the favored therapy for Strongyloides infections.

Fig. 32.2, Larva currens. Biopsy demonstrates migrating larva of Strongyloides stercoralis in the dermis.

Are there other nematode infestations that cause skin disease?

Enterobius vermicularis (pinworms) may cause a bothersome perianal itch, but secondary complications including dermatitis, bacterial infections, and local abscesses can develop. Treatment is one dose of mebendazole or albendazole, repeated in 2 weeks. Trichinella spiralis , which is acquired by eating undercooked pork, may cause a diffuse rash, nail bed splinter hemorrhages, and a subtle but persistent periorbital edema (trichinosis).

How do filarial infections differ from other nematode infections?

All the filariae have an insect vector integral to their life cycle and live in pairs within their mammalian host. The microfilarial offspring of this couple are the primary source of morbidity. The most important filarial diseases are filariasis, loiasis, and onchocerciasis ( Table 32.1 ).

Table 32.1
Parasitic Infestations of the Skin
PARASITIC INFESTATION VECTOR OR MODE OF TRANSMISSION
Filariasis Mosquito
Onchocerciasis Black fly
Creeping eruption Soil contact and larval penetration
African trypanosomiasis Tsetse fly
American trypanosomiasis Kissing bug
Leishmaniasis Sand fly
Schistosomiasis Water contact and cercarial penetration
Dracunculiasis, sparganosis Ingestion of larva
Echinococcosis, cysticercosis Ingestion of cysts
Amebiasis Direct contact or ingestion of cysts
Loiasis Horse and deer flies
Demodex Person-to-person contact in childhood

Where is onchocerciasis most prevalent? How is it transmitted?

Onchocerciasis, a disease produced by the tissue nematode Onchocerca volvulus , affects millions of people in Africa and Central and South America. The infective larval forms are transmitted to humans through the bite of the black fly ( Simulium ) ( Fig. 32.3 ). The common term for onchocerciasis, river blindness , takes its name from its feared complication and the fast-flowing rivers where the parasite and vectors are found. Elimination of onchocerciasis remains a major priority of the World Health Organization, and vaccines are under investigation.

Fig. 32.3, Simulium species. Black fly caught in the act of biting one of the editors (JEF). Note the small size compared with the hair shafts.

Nguyen JC, Murphy ME, Nutman TB, et al. Cutaneous onchocerciasis in an American traveler. Int J Dermatol. 2005;44:125–128.

Does river blindness cause cutaneous manifestations?

As the larval forms of Onchocerca develop into adult worms at the site of the bite, they produce subcutaneous nodules called onchocercomas, where numerous microfilariae are produced. They migrate into the skin, inducing a secondary dermatitis, skin pigmentation changes, skin thickening, frank elephantiasis, and an often disabling itching. The microfilariae also may migrate into the tissue of the eye and produce blindness due to severe uveal and corneal inflammation.

What are some of the problems with onchocerciasis treatment?

Diethylcarbamazine (DEC) is an effective treatment for the microfilarial stage and was used historically before 1990, but a hypersensitivity reaction to large numbers of dying parasites in the anterior chamber of the eye may cause irreversible blindness and, in some cases, death. This reaction in patients with onchocerciasis receiving DEC is considered a dangerous diagnostic sign, called the “Mazotti reaction.” DEC is now contraindicated for onchocerciasis. Also a safe treatment used historically, in otherwise asymptomatic victims, was periodic “nodulectomy,” which removes the adult worms and significantly lowers the morbidity of onchocerciasis. Now, however, ivermectin is the drug of choice for onchocerciasis. Ivermectin is being used for both individual treatment and as part of community onchocerciasis control. Of note, encephalopathy has been rarely reported in patients receiving Ivermectin who coexistent loiasis infection.

Omura S, Crump A. Ivermectin: panacea for resource-poor communities? Trends Parasitol. 2014;30(9):445–455.

Turner HC, Walker M, Churcher TS, et al. Reaching the London declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Infect Dis. 2014;59(7):923–932.

Babalola OE. Ocular onchocerciasis: current management and future prospects. Clin Ophthalmol . 2011;5:1479–1491.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here